Anavex Life Sciences Strengthens Board of Directors

Anavex Life Sciences Strengthens Board of Directors

NEW YORK – February 13, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...